NICE Recommends Routine NHS Use of Pregnancy-Specific Artificial Pancreas for Type 1 Diabetes
NICE recommends a pregnancy-specific artificial pancreas for women with type 1 diabetes, paving the way for NHS access.
NICE and MHRA decisions, newly approved medicines and treatments, and the rules that govern how care is delivered.
NICE flags pregnancy-specific ‘artificial pancreas’ device for women with type 1 diabetes
NICE has proposed a pregnancy-specific artificial pancreas for women with type 1 diabetes, aiming to improve NHS maternity and diabetes care.
NICE signals faster NHS access to new medicines as aligned approval pathway begins
NICE and MHRA launch an aligned pathway to speed NHS access to new medicines, with first guidance expected in June 2026.
NICE Moves to Expand Routine NHS Access to SMA Treatments
NICE recommends routine NHS access to nusinersen and risdiplam for eligible SMA patients in England.
NICE Opens the Door to Routine NHS Use of Liver Preservation Machines
NICE has opened consultation on liver preservation machines that could expand routine NHS access and help more transplant patients.
NHS Guidance Moves to Clarify Single-Sex Spaces for Staff
NHS guidance confirms single-sex staff spaces must be based on biological sex, prompting policy reviews across UK hospitals.
NICE Opens NHS Access to New Liver Preservation Machines in Bid to Save More Transplants
NICE has proposed liver preservation machines for NHS use, aiming to help more patients waiting for life-saving transplants.
NICE backs home antibiotics for some newborns as NHS infection care shifts closer to home
NICE has updated neonatal infection guidance, allowing some newborns to finish antibiotics at home if they are responding well.
NICE Recommends Home-Based Antibiotics for Some Newborns in Updated Infection Guidance
NICE updates neonatal infection guidance, allowing some newborns to finish antibiotics at home and potentially leave hospital sooner.
NICE Gives Routine NHS Access to Two SMA Treatments in England
NICE recommends routine NHS access to nusinersen and risdiplam for certain patients with spinal muscular atrophy in England.
